GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SMS Lifesciences India Ltd (BOM:540679) » Definitions » EV-to-Revenue

SMS Lifesciences India (BOM:540679) EV-to-Revenue : 1.12 (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is SMS Lifesciences India EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SMS Lifesciences India's enterprise value is ₹3,415 Mil. SMS Lifesciences India's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3,060 Mil. Therefore, SMS Lifesciences India's EV-to-Revenue for today is 1.12.

The historical rank and industry rank for SMS Lifesciences India's EV-to-Revenue or its related term are showing as below:

BOM:540679' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.16   Med: 0.64   Max: 1.29
Current: 1.12

During the past 9 years, the highest EV-to-Revenue of SMS Lifesciences India was 1.29. The lowest was 0.16. And the median was 0.64.

BOM:540679's EV-to-Revenue is ranked better than
86.27% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs BOM:540679: 1.12

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), SMS Lifesciences India's stock price is ₹801.20. SMS Lifesciences India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,011.71. Therefore, SMS Lifesciences India's PS Ratio for today is 0.79.


SMS Lifesciences India EV-to-Revenue Historical Data

The historical data trend for SMS Lifesciences India's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMS Lifesciences India EV-to-Revenue Chart

SMS Lifesciences India Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.45 0.79 0.86 0.87 1.05

SMS Lifesciences India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.51 0.85 0.57 1.05

Competitive Comparison of SMS Lifesciences India's EV-to-Revenue

For the Biotechnology subindustry, SMS Lifesciences India's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMS Lifesciences India's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SMS Lifesciences India's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where SMS Lifesciences India's EV-to-Revenue falls into.



SMS Lifesciences India EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

SMS Lifesciences India's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3414.571/3059.575
=1.12

SMS Lifesciences India's current Enterprise Value is ₹3,415 Mil.
SMS Lifesciences India's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,060 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SMS Lifesciences India  (BOM:540679) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

SMS Lifesciences India's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=801.20/1011.707
=0.79

SMS Lifesciences India's share price for today is ₹801.20.
SMS Lifesciences India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,011.71.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SMS Lifesciences India EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of SMS Lifesciences India's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SMS Lifesciences India (BOM:540679) Business Description

Traded in Other Exchanges
Address
Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
SMS Lifesciences India Ltd is engaged in the Business of manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, and Erectile Dysfunction.

SMS Lifesciences India (BOM:540679) Headlines

No Headlines